On the Edge: Targeting Toll-Like Receptor 2 in Ischemia/Reperfusion Injury

Circulation: Cardiovascular Interventions - United States
doi 10.1161/circinterventions.112.968495
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)